Skip to content

Analgesic effect of oxycodone and remifentanil in patients undergoing mechanical ventilation in ICU

Analgesic effect of oxycodone and remifentanil in patients undergoing mechanical ventilation in ICU

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091747
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-06-26
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

oxycodone group:After tracheal intubation and mechanical ventilation, immediate sedative and analgesic treatment was performed. The initial plan was for the study group to receive intravenous infusion
Remifentanil group:After tracheal intubation and mechanical ventilation, immediate sedative and analgesic treatment was performed. The initial plan was for the study group to receive intravenous infus

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 89 Years

Inclusion criteria

Inclusion criteria: (1) Age>18 years old,24 hours;

Exclusion criteria

Exclusion criteria: (1) Stay in the ICU for at least 1 week before enrollment; (2) Having symptoms of drug use, delirium, alcohol withdrawal, or mental illness, or using antipsychotic drugs; (3) Study drug allergies or other contraindications; (4) Severe renal insufficiency combined with blood purification treatment is necessary; (5) Combined severe liver dysfunction (Child Pugh grade C); (6) Comatose patients (GCS score<8 points); (7) Severe hypotension requiring high-dose vasoactive drugs to maintain blood pressure; (8) The patient or authorized client of the patient does not agree to participate in the study; (9) Pregnant or lactating women; (10) Deep sedation is required (oxygenation index = 100mmHg, loss of consciousness during muscle relaxant treatment, status epilepticus, absolute immobilization required for surgical or surgical conditions, severe traumatic brain injury with intracranial hypertension, therapeutic hypothermia, and other clinical evaluations requiring maintenance of RASS score<-2 points); (11) According to the condition, it is expected that mechanical ventilation support will be required for a long time, such as peripheral neuromuscular diseases, brainstem injuries, and respiratory center involvement.

Design outcomes

Primary

MeasureTime frame
heart rate;mean arterial pressure;Translate Vasoactive drug dosage Vasoactive drug dosage;Respiratory rate;Oxygenation index;Platform pressure;airway peak pressure;airway resistance ;Static compliance;Respiratory work;

Secondary

MeasureTime frame
Average hourly dose of analgesics to achieve analgesic goals;Average sedative dose per hour to achieve sedative goals;Mechanical ventilation time;ICU hospitalization time;Adverse reaction incidence rate;

Countries

China

Contacts

Public ContactChen Li

Affiliated Hospital of North Sichuan Medical College

nsmcdxf@163.com+86 157 2961 9315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026